Document Detail


Novel use of 308-nm excimer laser to treat a primary cutaneous CD30+ lymphoproliferative nodule.
MedLine Citation:
PMID:  17668543     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
CD30+ cutaneous lymphoproliferative disorders, the second most common cutaneous T cell lymphoma after mycosis fungoides, represent a spectrum of conditions ranging from lymphomatoid papulosis to borderline CD30+ lesions to anaplastic large-cell lymphoma. We report the case of a solitary cutaneous CD30+ lymphoproliferative nodule that was successfully treated with a 308-nm excimer laser. Our findings suggest that the 308-nm excimer laser may be a safe, effective, and well-tolerated therapy for primary localized CD30+ cutaneous lymphoproliferative lesions.
Authors:
John L Meisenheimer
Related Documents :
22784523 - Necrobiosis lipoidica diabeticorum in a tattoo site.
19843083 - Angiokeratoma: a cutaneous marker of fabry's disease.
492663 - Treatment of the lacrimal excretory system after resection of medial canthal and eyelid...
Publication Detail:
Type:  Case Reports    
Journal Detail:
Title:  Journal of drugs in dermatology : JDD     Volume:  6     ISSN:  1545-9616     ISO Abbreviation:  J Drugs Dermatol     Publication Date:  2007 Apr 
Date Detail:
Created Date:  2007-08-02     Completed Date:  2007-08-27     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  101160020     Medline TA:  J Drugs Dermatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  440-2     Citation Subset:  IM    
Affiliation:
South Orlando Dermatology, Orlando, FL 32819, USA. luckyj@msn.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antigens, CD30 / analysis*
Diagnosis, Differential
Humans
Insect Bites and Stings / diagnosis
Laser Therapy, Low-Level / methods*
Lymphoma, Large-Cell, Anaplastic / diagnosis,  immunology,  therapy*
Lymphomatoid Papulosis / diagnosis,  immunology,  therapy*
Male
Middle Aged
Time Factors
Treatment Outcome
Chemical
Reg. No./Substance:
0/Antigens, CD30

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Paecilomyces lilacinus infection with a sporotrichoid pattern in a renal transplant patient.
Next Document:  Positive impact of chloroquine on delayed pressure urticaria.